Abandoned Development. [***], no Active Development Activities (as defined below) have been conducted by Zai, its Affiliates or permitted Sublicensee within ten (10) months of the Effective Date, and (b) such inactivity was not caused by a Serious Adverse Event or Serious Adverse Drug Reaction (each as defined in the Pharmacovigilance Agreement) reported pursuant to the Pharmacovigilance Agreement, Regulatory Authority or was not due to a force majeure event or ▇▇▇▇▇▇▇▇’▇ failure to supply sufficient quantities of Clinical Supply Product to Zai, then Zai shall be deemed to have abandoned the Development under the applicable Development Plan for the Product therein (“Abandoned Development”). If Zai has Abandoned Development, then ▇▇▇▇▇▇▇▇ shall have the right to terminate this Agreement in accordance with Section 14.4(a). “Active Development Activities” [***].
Appears in 2 contracts
Sources: License Agreement (Zai Lab LTD), License Agreement (Cullinan Oncology, LLC)